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Inflammatory pseudotumor is a non-neoplastic process of unknown etiology 
characterized by a proliferation of connective tissue with an inflammatory infiltrate. 
Intracranial inflammatory pseudotumors classically involve the cavernous sinus but can 
also occur in the supratentorial or infratentorial compartments and spinal canal.
Symptoms are dependent on location, and when present in the cavernous sinus, typically 
include cranial nerve palsies of those nerves in the cavernous sinus. These lesions are 
rapidly responsive to steroid therapy. Surgery is typically indicated for biopsy only, but 
complete resection may be justified for lesions outside the cavernous sinus.
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Inflammatory pseudotumor of the orbit was initially described in 1903 by Busse 
and Hochheim [21, 42], but it was not until 1980 that intracranial involvement was 
reported [80]. These lesions develop as a non-neoplastic process of unknown origin 
characterized by a proliferation of connective tissue with an inflammatory infiltrate [64]. 
The lung [7] and liver [4, 73] are the two most common sites of inflammatory 
pseudotumor, but the lesions have been described in the stomach [74], pancreas [2], heart 
[33], kidney [27], bladder [15, 20], and skin [40]. Central nervous system inflammatory 
pseudotumors are exceptionally uncommon and typically arise from the meninges [3]. 
Intracranial inflammatory pseudotumor involving the cavernous sinus with resultant 
painful ophthalmoplegia was classically described by Tolosa [77] and Hunt et al. [39], 
and is now referred to as the Tolosa-Hunt syndrome [38]. We present an illustrative case 
of a large inflammatory pseudotumor that involved bilateral cavernous sinuses and the 
clivus, and a review of the contemporary literature.
Illustrative Case
This 28-year-old, previously healthy man developed headache, nausea, dizziness, 
and double vision one week after extensive dental work. At an outside institution, he was 
noted to have a right sixth cranial nerve palsy. The evaluation at that hospital included a 
magnetic resonance imaging (MRI) scan, which was interpreted as being consistent with 
cavernous sinus thrombosis, and a lumbar puncture that revealed cerebrospinal fluid with 
elevated protein and white cells. Subsequently, the patient was treated empirically with 
warfarin (Coumadin), steroids, and cephalosporin (Rocephin) for presumed sinus


































thrombosis secondary to an infectious process. After initiation of treatment, the double 
vision, headache, and nausea, dizziness improved. A steroid taper was attempted after a 
full course of cephalosporin, but the same symptoms returned.
The patient was referred to our institution where his neuroradiological workup 
included MRI studies that revealed extensive meningeal thickening and enhancement 
primarily involving the bilateral cavernous sinuses, high posterior clinoid area, and distal 
petrous internal carotid artery canals (Fig. 1A-F). The differential diagnosis included 
meningioma and inflammatory pseudotumor. An endonasal transsphenoidal partial 
excision of the clivus lesion was performed to acquire a specimen for histopathological 
analysis. Intraoperatively, an erosive process of the clivus was observed with a lesion 
that was mucinous in character. The histopathological findings demonstrated nonspecific 
acute and chronic inflammatory fibrosis consistent with inflammatory pseudotumor (Fig. 
2). No neoplastic process was identified. No organisms were cultured from the biopsy 
material.
The patient continued steroid treatment with 70 mg of prednisone daily after the 
diagnosis of inflammatory pseudotumor was established. His headaches continued but 
were diminished, and the diplopia completely resolved. No new symptoms have 
developed. A follow-up MRI one year after biopsy demonstrated near complete 
resolution of the pseudotumor (Fig. IG). A steroid taper was initiated, which the patient 
tolerated without a return of symptoms. Still, one year after biopsy, he has continued on 
physiologic steroid doses due to symptoms consistent with systemic withdraw.
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Inflammatory pseudotumor has been referred to by several names in the literature, 
including plasma cell granuloma [7, 18, 49], inflammatory fibrosarcoma [54], 
inflammatory myofibroblastic tumor [63, 71], inflammatory myofibrohistiocytic 
proliferation [76], fibrohistiocytoma [52], xanthomatous pseudotumor [14], and plasma 
cell-histiocytoma complex [72]. The multiple terms given to this single pathologic entity 
reflect the variable compositions of inflammatory pseudotumor. The pathologic 
specimen in the illustrative case demonstrated a combination of fibrous stroma, acute and 
chronic inflammatory processes, and a lymphoid infiltrate composed of both B- and T- 
cells. All of these components are typical of an inflammatory pseudotumor, but the 
degree of fibrous stroma and specific inflammatory cells involved can vary greatly [8, 48, 
70]. Plasma cells frequently predominate, but they may be outnumbered by lymphocytes 
[76]. Other cellular constituents can include histiocytes, macrophages, and eosinophils 
[14, 26, 40]. The polyclonality of the plasma cells, demonstrated by the presence of both 
kappa and lambda light chains with immunohistochemical staining, distinguishes 
inflammatory pseudotumor from monoclonal processes such as plasmacytoma and 
lymphoma [3, 64]. A subset of inflammatory pseudotumors have monoclonal plasma 
cells, but this has only been described in two cases [37, 79].
Etiology
The etiology of inflammatory pseudotumor is unknown, but it has been associated 
with a number of diseases processes including Sjogren’s disease [17], Epstein-Barr virus 
[5, 6, 34], human immunodeficiency virus [75], polymyositis [3], and neuro-Beh§et’s 
disease [32, 62]. al-Sarraj et al. [3] proposed that inflammatory pseudotumor is the result


































of an exaggerated immunological process, which is supported by evidence of the 
elevation of serum immunoglobulins [12]. The immunological response could 
potentially be triggered by a viral or bacterial infection [30]. Viral infections appear to be 
a more likely culprit, because Epstein-Barr virus has been associated with up to 40% of 
inflammatory pseudotumor cases [6], whereas histopathological evaluation does not 
demonstrate bacteria [64] (as in the illustrative case). In other cases, the immunological 
response may not need to be triggered per se but instead may result from an autoimmune 
disorder, given the association between inflammatory pseudotumors and several 
autoimmune diseases.
Location and Presenting Symptoms
The location of the mass has a significant impact on which symptoms are 
produced by intracranial inflammatory pseudotumor. Cavernous sinus involvement 
typically causes painful ophthalmoplegia (i.e., Tolosa-Hunt syndrome), but painless 
ophthalmoplegia can also occur [29]. Stenosis of the intracavemous intracerebral artery 
can lead to transient ischemic attacks [10]. In rare instances, inflammatory pseudotumor 
has been reported to have an intrasellar component, resulting in hypopituitarism [31, 60] 
or to extend to Meckel’s cave, causing facial pain [51, 60]. In the present case, the 
inflammatory pseudotumor extended to the clivus, where an abducens nerve palsy could 
potentially have been caused by compression of the nerve as it traverses Dorello’s canal. 
Alternatively, the abducens palsy could have been caused by direct cavernous sinus 
involvement.


































Besides the sellar and parasellar areas, other intracranial locations of 
inflammatory pseudotumors have included the tentorium [80], falx [57], spinal cord 
meninges [26], lateral ventricle (choroid plexus) [12, 64], fourth ventricle [3, 59], and 
intraparenchymal regions [16, 76]. Lesions are usually solitary, but multiple intracranial 
inflammatory pseudotumors in the same patient do occur [16, 53].
Radiographic Appearance
In general, inflammatory pseudotumors have nonspecific neuroradiologic 
findings. Inflammatory pseudotumors are iso- to hypointense on Tl-weighted MRI, 
hypointense on T2-weighted MRI, and homogeneously enhancing [12, 35, 48, 64]. They 
can be hypercellular, and therefore MRI spectroscopy cannot reliably distinguish these 
lesions from neoplasms [46]. Infrequently, bony erosion can occur [31, 48]. In this 
circumstance, distinguishing between an inflammatory pseudotumor and destructive 
neoplasm or infectious process is difficult without the aid of a biopsy [35]. Inflammatory 
pseudotumors can also be difficult to differentiate from meningiomas, because both 
lesions are generally homogeneously enhancing and are often associated with the 
meninges. The hypointensity on T2-weighted MRI can help differentiate inflammatory 
pseudotumors from other lesions of the skull base that are iso- or hyperintense on the 
same imaging sequence, including chordomas, chondrosarcomas, nasopharyngeal 
carcinomas, and metastatic malignant tumors [35].
Treatment


































Steroid therapy is the cornerstone of treatment for inflammatory pseudotumor, 
especially with involvement of the cavernous sinus. Cranial nerve palsies usually 
respond quickly to steroid therapy, and the diagnosis of inflammatory pseudotumor 
should be questioned if steroids do not help alleviate symptoms. The International 
Headache Society in 1988 defined specific criteria for diagnosing Tolosa-Hunt syndrome 
and included a response to steroids within 72 hours as one of those criteria [1]. One 
possible exception is when the lesion has a large fibrosis component, indicating a more 
chronic process, in which steroids are less effective [36, 67]. The optimal steroid dose 
and schedule for inflammatory pseudotumor of the cavernous sinus or skull base is 
unclear. For inflammatory pseudotumor of the orbit, two weeks of prednisone 
(1/mg/kg/d), or an equivalent steroid, followed by a taper over weeks to months is 
standard [24, 56, 66]. In case reports involving the cavernous sinus or skull base (Table 
1), steroid doses varied greatly with treatment ranging from one to eight months. The 
steroid dose used for inflammatory pseudotumor of the orbit likely applies to lesions of 
the cavernous sinus and skull base, with the duration of treatment being titrated to clinical 
response.
Recurrence rates after steroid treatment are difficult to assess for intracranial 
inflammatory pseudotumors because most publications consist of single case reports. Of 
the 17 cases listed in Table 1 that received steroids, only two (12%) had progression or 
recurrence of symptoms, but it should be noted that several of those cases received 
multiple treatment modalities besides steroids, including radiation and surgery. Series of 
orbital inflammatory pseudotumor cases have found a recurrence rate of 25% to 77% [50,


































55, 56, 68, 78]. Rarely, recurrence can occur ten or more years after completion of 
steroid therapy [9, 11].
If recurrence does occur, then a longer course of steroids is indicated, and 
response to treatment may be monitored with serial imaging studies. For cases 
unresponsive to steroids, radiation treatment is a reasonable alternative. Doses between 
2000 and 4000 rad have been delivered for intracranial inflammatory pseudotumor with a 
positive clinical response [22, 28, 44, 58]. When the cavernous sinus is involved, surgery 
may be indicated to perform a biopsy and confirm a diagnosis, but complete surgical 
resection is usually not an option because of the high risk of causing additional cranial 
neuropathies. Complete surgical resection is possible with lesions in other locations, 
such as the ventricles or infratemporal fossa.
For rare cases that are refractory to both steroid therapy and radiation therapy, 
other immunosuppressant or chemotherapeutic medications may be considered [43]. In a 
review of three patients who received the antimetabolite methotrexate for treatment of 
orbital inflammatory pseudotumor, because of contraindications or failure of steroid 
therapy, two of the patients had a reduction in inflammation whereas the third patient had 
no response [69]. Cyclosporine has also been effective in controlling orbital 
inflammatory pseudotumor when a patient with diabetes could not tolerate steroids 
because of poor glucose control [25]. Anecdotal reports have also suggested that 
azathioprine [23] and infliximab [82] can contribute to treatment regimens.
Conclusion
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Inflammatory pseudotumor is a non-neoplastic proliferation of connective tissue
with an inflammatory infiltrate that can occur throughout the brain. These masses should
c especially be considered when a lesion is homogeneously enhancing and is associatedc
1
& with the meninges in the sella or parasellar areas. Extension to surrounding structures,
>cr-h such as the clivus and Meckel’s cave, can also occur. Symptoms, particularly cranial
0K nerve palsies, are rapidly responsive to steroid therapy. Surgery is often required to
P13Ccr>o acquire a biopsy specimen, but complete resection is usually not possible with the
rt- involvement of the cavernous sinus.
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Figure 1: Magnetic resonance images demonstrating extensive meningeal thickening 
and enhancement primarily involving the bilateral cavernous sinuses, superior clivus 
region, and distal petrous internal carotid artery canals. The lesion is enhancing of post­
gadolinium T1-weighted sequences (A-D), isointense on T1-weighted sequences without 
gadolinium (E), and hypointense on T2-weighted sequences (F). (G) Post-gadolinium Tl- 
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Figure 2: Histopathology demonstrating nonspecific acute and chronic inflammatory 
changes, including plasma cells (long black arrow), lymphocytes (short white arrow), 
foamy cells (short black arrow), and fibroblasts (long white arrow). The diverse 
population of inflammatory cells is in contradistinction to a lymphoma, which has a 











Table 1: Summary of reported cases of inflammatory pseudotumor or plasma cell 
granuloma involving the cavernous sinus or skull base identified by a PubMed search. 
Lesions involving the cavernous sinus are typically treated non-operatively due to the 
high risk of surgical morbidity. Steroids, with or without radiation, are usually effective 
in completely treating or stabilizing inflammatory pseudotumor, with only two reported 
cases of disease progression or recurrence during follow-up ranging from two months to 
four years. Steroid dosing and duration of treatment were highly variable. Other 
locations such as the infratemporal fossa can be amenable to surgical to resection.
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